Schulze-Osthoff K, Krammer PH, Droge W: Divergent signalling via

Schulze-Osthoff K, Krammer PH, Droge W: Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell

death. EMBO J 1994, 13:4587–4596.PubMed 26. Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A, Herceg Z, Wang ZQ, Schulze-Osthoff K: Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell 2002, 13:978–988.PubMedCrossRef 27. Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, Huang DC, Wu Lee YH, Durkop H, Engelmann H, Scheurich selleck products P, et al.: Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 1999, 18:3034–3043.PubMedCrossRef 28. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J: Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005, 1:112–119.PubMedCrossRef 29. Kawahara A, Ohsawa Y, CUDC-907 solubility dmso Matsumura H, Uchiyama Y, Nagata S: Caspase-independent cell killing by Fas-associated protein with death domain. J Cell Biol 1998, 143:1353–1360.PubMedCrossRef

30. Lawrence CP, Chow SC: FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death. FEBS Lett 2005, 579:6465–6472.PubMedCrossRef 31. Laukens B, Jennewein C, Schenk B, Vanlangenakker N, Schier A, Cristofanon

S, Zobel K, Deshayes K, Vucic D, Jeremias I, et al.: Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis selleck inhibitor factor alpha-induced necroptosis. Neoplasia 2011, 13:971–979.PubMed 32. Takada Y, Sung B, Sethi G, Chaturvedi MM, Aggarwal BB: Evidence that genetic deletion of the TNF receptor p60 or p80 inhibits Fas mediated Pregnenolone apoptosis in macrophages. Biochem Pharmacol 2007, 74:1057–1064.PubMedCrossRef 33. Scheurich P, Thoma B, Ucer U, Pfizenmaier K: Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol 1987, 138:1786–1790.PubMed 34. Scheurich P, Unglaub R, Maxeiner B, Thoma B, Zugmaier G, Pfizenmaier K: Rapid modulation of tumor necrosis factor membrane receptors by activators of protein kinase C. Biochem Biophys Res Commun 1986, 141:855–860.PubMedCrossRef 35. Cubillas R, Kintner K, Phillips F, Karandikar NJ, Thiele DL, Brown GR: Tumor necrosis factor receptor 1 expression is upregulated in dendritic cells in patients with chronic HCV who respond to therapy. Hepat Res Treat 2010, 2010:429243.PubMed 36. Saito T, Dworacki G, Gooding W, Lotze MT, Whiteside TL: Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma. Clin Cancer Res 2000, 6:1351–1364.PubMed Competing interests The authors declare that they have no competing interests.

Comments are closed.